echemi logo
web-logo
slogan
homepage
Product
  • Product
  • Supplier
  • Inquiry

    My ECHEMI

    EN

    Home > Medical News > Medical Research Articles > The Phase III clinical study results of PD-L1 inhibitor adebelimumab were listed in The Lancet-Oncology

    The Phase III clinical study results of PD-L1 inhibitor adebelimumab were listed in The Lancet-Oncology

    • Last Update: 2022-08-15
    • Source: Internet
    • Author: User
    Tags

    opdivo drug

    selenium cancer
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com